Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patil

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
The Lancet Regional Health. Southeast Asia|June 29, 2023
Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation - a randomised trialVijay Patil, Vanita Noronha, Nandini Menon, et al.
Journal of Neuro-Oncology|January 17, 2022
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic studyPrithwijit Moitra, Abhishek Chatterjee, Priti Khatri Kota, et al.
Lung Cancer (Auckland, N.Z.)|February 19, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisShruti Kate, Anuradha Chougule, Amit Joshi, et al.
Biosensors & Bioelectronics|June 27, 2014
A novel fluorescent "turn-on" chemosensor for nanomolar detection of Fe(III) from aqueous solution and its application in living cells imagingJitendra Nandre, Samadhan Patil, Vijay Patil, et al.
South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
BMJ Open|February 16, 2021
Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancerAnil Tibdewal, JaiPrakash Agarwal, Naveen Mummudi, et al.
Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.
Ecancermedicalscience|March 28, 2019
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomesAmit Joshi, Nikhil Pande, Vanita Noronha, et al.
Chemotherapy Research and Practice|December 31, 2014
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC PatientsVanita Noronha, Amit Joshi, Anant Gokarn, et al.
Oral Oncology|September 24, 2021
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trialNandini Menon, Vijay Patil, Vanita Noronha, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
The Lancet Regional Health. Southeast Asia|June 29, 2023
Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation - a randomised trialVijay Patil, Vanita Noronha, Nandini Menon, et al.
Journal of Neuro-Oncology|January 17, 2022
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic studyPrithwijit Moitra, Abhishek Chatterjee, Priti Khatri Kota, et al.
Lung Cancer (Auckland, N.Z.)|February 19, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisShruti Kate, Anuradha Chougule, Amit Joshi, et al.
Biosensors & Bioelectronics|June 27, 2014
A novel fluorescent "turn-on" chemosensor for nanomolar detection of Fe(III) from aqueous solution and its application in living cells imagingJitendra Nandre, Samadhan Patil, Vijay Patil, et al.
South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
BMJ Open|February 16, 2021
Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancerAnil Tibdewal, JaiPrakash Agarwal, Naveen Mummudi, et al.
Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.
Ecancermedicalscience|March 28, 2019
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomesAmit Joshi, Nikhil Pande, Vanita Noronha, et al.
Chemotherapy Research and Practice|December 31, 2014
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC PatientsVanita Noronha, Amit Joshi, Anant Gokarn, et al.
Oral Oncology|September 24, 2021
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trialNandini Menon, Vijay Patil, Vanita Noronha, et al.
Pageof 19